Chargement en cours...

Modulation of Sodium Iodide Symporter in Thyroid Cancer

Radioactive iodine (RAI) is a key therapeutic modality for thyroid cancer. Loss of RAI uptake in thyroid cancer inversely correlates with patient’s survival. In this review, we focus on the challenges encountered in delivering sufficient doses of I-131 to eradicate metastatic lesions without increas...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Horm Cancer
Auteurs principaux: Lakshmanan, Aparna, Scarberry, Daniel, Shen, Daniel H., Jhiang, Sissy M.
Format: Artigo
Langue:Inglês
Publié: Springer US 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458071/
https://ncbi.nlm.nih.gov/pubmed/25234361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-014-0203-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!